GSK, 31 South Korean pharma companies, distributors fined for bid rigging on vaccine procurement
MLex Summary: GlaxoSmithKline and 31 other South Korean pharmaceutical companies and vaccine distributors were hit with a combined fine of 40.9 billion won ($32 million) and corrective orders for rigging bids...To view the full article, register now.
Already a subscriber? Click here to view full article